Markets › United States › NYSE › LH

Labcorp Holdings Inc

NYSE:LHHealthcareCBOE:SPESGSTOXX:EDD24BP

$318.83+0.28%At closeAt close · Tue 20 Oct · ≈ AED 1,170.90 · Market cap $25.86B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	35.4%	38.0%	31.3%	27.7%	27.9%	26.8%	—	—
Operating margin	17.5%	23.2%	12.1%	6.0%	8.4%	10.9%	10.9%	+0.0 pts
Net margin	11.1%	18.1%	10.8%	3.4%	5.7%	6.3%	6.3%	+0.0 pts
EBITDA margin	23.3%	28.0%	16.5%	11.1%	13.9%	14.4%	—	—
Return on equity	16.5%	23.1%	12.7%	5.3%	9.3%	10.2%	10.2%	−0.0 pts
Return on assets	7.8%	11.7%	6.3%	2.5%	4.1%	4.8%	4.8%	+0.0 pts
Return on capital employed	14.4%	17.3%	8.4%	5.4%	7.2%	9.7%	—	—
Debt / equity	0.7×	0.6×	0.6×	0.8×	0.9×	0.8×	0.8×	−0.2%
Debt / assets	33.7%	31.1%	31.0%	35.6%	39.6%	39.2%	—	—
Interest coverage	11.8×	14.4×	8.0×	3.6×	5.2×	6.8×	—	—
Current ratio	1.7×	1.9×	1.5×	1.2×	1.4×	1.4×	1.4×	+0.0%
Quick ratio	1.5×	1.8×	1.3×	1.0×	1.3×	1.2×	—	—
Cash ratio	0.4×	0.5×	0.1×	0.2×	0.5×	0.2×	0.2×	+0.0%
Asset turnover	0.7×	0.6×	0.6×	0.7×	0.7×	0.8×	—	—
Inventory turnover	21.3×	20.3×	17.3×	18.5×	19.0×	19.1×	—	—
Receivables turnover	4.6×	4.4×	5.9×	5.8×	6.2×	6.2×	—	—
Dividend payout	0.0%	0.0%	15.3%	60.8%	32.6%	27.5%	—	—